RecruitingNCT06396871

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases


Sponsor

Technische Universität Dresden

Enrollment

180 participants

Start Date

Oct 16, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question\[s\] it aims to answer are: * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Fibroscan of the Liver, Liver Ultrasound, and others for people with diabetes mellitus, nafld, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTOral glucose tolerance test

75g of a standardized glucose solution followed by blood draw at 0, 30, 60, 90, 120 min

DIAGNOSTIC_TESTLiver Ultrasound

A crude assessment of liver status in order to identify the presence of steatosis or not will take place with ultrasound.

DIAGNOSTIC_TESTFibroscan of the Liver

FibroScan non-invasively measures the stiffness of the liver by capturing and calculating the speed of a shear wave as it travels through the liver (vibration controlled transient elastography).

DIAGNOSTIC_TESTMagentic Resonance Imaging (MRI) of the liver

The exact calculation of liver fat with proton density fat fraction will take place with MRI.


Locations(1)

University Study Center for Metabolic Diseases

Dresden, Saxony, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06396871


Related Trials